Amphista Therapeutics Limited
11119959
Some Concerns
- No accounts filed in last 18 months (-5)
- Negative net worth (-10)
- Loss before tax (-10)
- Current liabilities exceed current assets (-10)
- 1 outstanding charge (-2)
Details
Compliance
Last accounts
31/12/2024
group
Next accounts due
30/09/2026
Confirmation statement
Last: 06/12/2025
Due 20/12/2026
Industry
Officers
director · Since 12/03/2021
VENTURE CAPITAL INVESTOR
SWISS · NETHERLANDS · Age 42
director · Since 12/03/2021
VENTURE CAPITALIST
DUTCH · NETHERLANDS · Age 42
Also on 1 other board
director · Since 16/05/2022
VENTURE CAPITAL
BRITISH · UNITED KINGDOM · Age 44
Also on 1 other board
director · Since 09/12/2022
INVESTMENT MANAGER
LUXEMBOURGER · GERMANY · Age 43
Also on 2 other boards
Persons with Significant Control
Former PSCs
Advent Life Sciences Fund Ii Lp
Ceased 20/12/2017
Advent Life Sciences Llp
Ceased 27/02/2018
Dr Alessio Ciulli
Ceased 28/06/2019
Advent Life Sciences Llp
Ceased 12/12/2022
Advent Life Sciences Fund Ii Lp
Ceased 28/06/2019
Charges1 outstanding
HSBC INNOVATION BANKING FORMERLY KNOWN AS SILICON VALLEY BANK UK LTD
SILICON VALLEY BANK
CompanyRankvs 23950+ SIC 72110 peers33
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2021
Turnover
£0
Annual revenue
Net Worth
-£4.7M
Balance sheet strength
Cash
£21.5M
Cash in the bank
Profit Before Tax
-£6.9M
Bottom line earnings
Net Current Assets
-£5.5M
Working capital
Current Assets
£24.5M
Current Liabilities
£31.7M
Fixed Assets
£881k
Debtors
£0
Cost of Sales
£0
Gross Profit
£0
Admin Expenses
£6.0M
Operating Profit
-£6.0M
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2021 | 0.77 |
Derived from filed accounts. Not audited figures.